The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Addus HomeCare (ADUS) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Addus HomeCare is one of 1050 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Addus HomeCare is currently sporting a Zacks Rank of #2 (Buy). Over the past three months, the Zacks Consensus Estimate for ADUS' full-year earnings has moved 2.8% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Based on the most recent data, ADUS has returned 6% so far this year. Meanwhile, stocks in the Medical group have gained about 2.3% on average. This means that Addus HomeCare is performing better than its sector in terms of year-to-date returns. HCA Healthcare (HCA) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 14.3%. Over the past three months, HCA Healthcare's consensus EPS estimate for the current year has increased 1.3%. The stock currently has a Zacks Rank #2 (Buy). To break things down more, Addus HomeCare belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 19 individual companies and currently sits at #151 in the Zacks Industry Rank. This group has gained an average of 4.7% so far this year, so ADUS is performing better in this area. On the other hand, HCA Healthcare belongs to the Medical - Hospital industry. This 5-stock industry is currently ranked #100. The industry has moved +14.9% year to date. Investors with an interest in Medical stocks should continue to track Addus HomeCare and HCA Healthcare. These stocks will be looking to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Addus HomeCare Corporation (ADUS):Free Stock Analysis Report HCA Healthcare, Inc. (HCA):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...